Perra M, Castangia I, Aroffu M, Fulgheri F, Abi-Rached R, Manca M
Discov Oncol. 2025; 16(1):73.
PMID: 39838217
PMC: 11751265.
DOI: 10.1007/s12672-025-01820-z.
Zhang X, Zhang H, Liu X, Wang J, Li S, Gao P
Polymers (Basel). 2024; 16(22).
PMID: 39599255
PMC: 11598018.
DOI: 10.3390/polym16223163.
Mishra A, Kumar R, Harilal S, Nigam M, Datta D, Singh S
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):497-532.
PMID: 39480523
DOI: 10.1007/s00210-024-03469-x.
Zheng R, Yu C, Yao D, Cai M, Zhang L, Ye F
Small. 2024; 21(1):e2406439.
PMID: 39444066
PMC: 11707583.
DOI: 10.1002/smll.202406439.
Son A, Park J, Kim W, Lee W, Yoon Y, Ji J
Biomolecules. 2024; 14(9).
PMID: 39334841
PMC: 11430650.
DOI: 10.3390/biom14091073.
Microenvironment-responsive nanosystems for ischemic stroke therapy.
Wu F, Zhang Z, Ma S, He Y, He Y, Ma L
Theranostics. 2024; 14(14):5571-5595.
PMID: 39310102
PMC: 11413776.
DOI: 10.7150/thno.99822.
Nanocarrier design for pathogen-inspired innate immune agonist delivery.
Kane G, Brassil M, Diaz-Infante M, Atukorale P
Trends Immunol. 2024; 45(9):678-692.
PMID: 39191543
PMC: 11492413.
DOI: 10.1016/j.it.2024.07.007.
Targeted Cancer Therapy-on-A-Chip.
Abed H, Radha R, Anjum S, Paul V, AlSawaftah N, Pitt W
Adv Healthc Mater. 2024; 13(29):e2400833.
PMID: 39101627
PMC: 11582519.
DOI: 10.1002/adhm.202400833.
Enhancing hair regeneration: Recent progress in tailoring nanostructured lipid carriers through surface modification strategies.
Atrooz O, Reihani N, Mozafari M, Salawi A, Taghavi E
ADMET DMPK. 2024; 12(3):431-462.
PMID: 39091900
PMC: 11289513.
DOI: 10.5599/admet.2376.
Advanced applications of smart electrospun nanofibers in cancer therapy: With insight into material capabilities and electrospinning parameters.
Tayebi-Khorrami V, Rahmanian-Devin P, Fadaei M, Movaffagh J, Askari V
Int J Pharm X. 2024; 8:100265.
PMID: 39045009
PMC: 11263755.
DOI: 10.1016/j.ijpx.2024.100265.
Designing Dual-Responsive Drug Delivery Systems: The Role of Phase Change Materials and Metal-Organic Frameworks.
Wei W, Lu P
Materials (Basel). 2024; 17(13).
PMID: 38998154
PMC: 11242594.
DOI: 10.3390/ma17133070.
ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
Wu P, Wang X, Yin M, Zhu W, Chen Z, Zhang Y
Int J Nanomedicine. 2024; 19:4465-4493.
PMID: 38779103
PMC: 11110815.
DOI: 10.2147/IJN.S443117.
Polymer-Based Drug Delivery Systems for Cancer Therapeutics.
Ding L, Agrawal P, Singh S, Chhonker Y, Sun J, Murry D
Polymers (Basel). 2024; 16(6).
PMID: 38543448
PMC: 10974363.
DOI: 10.3390/polym16060843.
Multifunctional Liposomes Co-Modified with Ginsenoside Compound K and Hyaluronic Acid for Tumor-Targeted Therapy.
You X, Liu H, Chen Y, Zhao G
Polymers (Basel). 2024; 16(3).
PMID: 38337294
PMC: 10857112.
DOI: 10.3390/polym16030405.
The utilization of nanotechnology in the female reproductive system and related disorders.
Luo X, Jia K, Xing J, Yi J
Heliyon. 2024; 10(3):e25477.
PMID: 38333849
PMC: 10850912.
DOI: 10.1016/j.heliyon.2024.e25477.
Pharmacokinetics and tumor delivery of nanoparticles.
Yuan L, Chen Q, Riviere J, Lin Z
J Drug Deliv Sci Technol. 2023; 83.
PMID: 38037664
PMC: 10686544.
DOI: 10.1016/j.jddst.2023.104404.
A pH-Responsive DNA Tetrahedron/Methotrexate Drug Delivery System Used for Rheumatoid Arthritis Treatment.
Jin Y, Ge X, Xu Y, Wang S, Lu Q, Deng A
J Funct Biomater. 2023; 14(11).
PMID: 37998110
PMC: 10672632.
DOI: 10.3390/jfb14110541.
Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy.
Sharma P, Otto M
Bioact Mater. 2023; 31:440-462.
PMID: 37701452
PMC: 10494322.
DOI: 10.1016/j.bioactmat.2023.08.022.
4-Dimensional printing: exploring current and future capabilities in biomedical and healthcare systems-a Concise review.
Agarwal N, Solanki V, Ameta K, Yadav V, Gupta P, Wanale S
Front Bioeng Biotechnol. 2023; 11:1251425.
PMID: 37675401
PMC: 10478005.
DOI: 10.3389/fbioe.2023.1251425.
Cetuximab-Conjugated Magnetic Poly(Lactic-co-Glycolic Acid) Nanoparticles for Dual-Targeted Delivery of Irinotecan in Glioma Treatment.
Dash B, Lu Y, Luo S, Chen J
Materials (Basel). 2023; 16(16).
PMID: 37629816
PMC: 10456415.
DOI: 10.3390/ma16165526.